Erratum: Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden (Nature Communications (2014) 5 (3756) DOI: 10.1038/ncomms4756);Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden

Nature Communications

Volumn 5, Issue , 2014, Pages

  Cazier, Jean Baptiste ^a,c   Rao, S R ^b   McLean, C M ^a,b   Walker, A L ^a,b   Wright, B J ^c   Jaeger, E E M ^c   Kartsonaki, C ^a   Marsden, L ^a,b   Yau, Chris ⁱ   Camps, C ^c   Kaisaki, P ^c   Taylor, Jenny ^c,g   Catto, J W ^d   Tomlinson, Ian ^c,g   Kiltie, A E ^a,b   Hamdy, F C ^a,b   Allan, Christopher ^c   Attar, Moustafa ^c   Bell, John ^e   Bentley, David ^f   Broxholme, John ^c   Buck, David ^c   Copley, Richard ^c   Cornall, Richard ^c   Donnelly, Peter ^c   Fiddy, Simon ^c   Green, Angie ^c   Gregory, Lorna ^c   Grocock, Russell ^f   Hatton, Edouard ^c   Holmes, Chris ^c   Hughes, Linda ^c   Humburg, Peter ^c   Humphray, Sean ^f   Kanapin, Alexander ^c   Kingsbury, Zoya ^f   Knight, Julian ^c   Lamble, Sarah ^c   Lise, Stefano ^c   Lonie, Lorne ^c   Lunter, Gerton ^c   Martin, Hilary ^c   Murray, Lisa ^f   McCarthy, Davis ^c   McVean, Gil ^c   Pagnamenta, Alistair ^c   Piazza, Paolo ^c   Polanco, Guadelupe ^c   Ratcliffe, Peter ^c   Rimmer, Andy ^c   Sahgal, Natasha ^c   Trebes, Amy ^c   Wilkie, Andrew ^g,h   Wright, Ben ^c   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e Richard Doll Building ^*  (United Kingdom)

^f ILLUMINA INC   (United States)

^g NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; FIBROBLAST GROWTH FACTOR RECEPTOR 3; K RAS PROTEIN; MESSENGER RNA; PROTEIN MDM2; PROTEIN P53; CADHERIN; CDKN1A PROTEIN, HUMAN; FAT1 PROTEIN, HUMAN;

CANCER; GENOME; MOLECULAR ANALYSIS; MUTATION; PATHOLOGY; PROTEIN; TUMOR;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; COPY NUMBER VARIATION; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; INDEL MUTATION; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NUCLEOTIDE SEQUENCE; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; BLADDER TUMOR; DNA SEQUENCE; GENETIC VARIABILITY; GENETICS; GENOME; MOLECULAR GENETICS; MUTATION;

BASE SEQUENCE; CADHERINS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENETIC VARIATION; GENOME; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM GRADING; SEQUENCE ANALYSIS, DNA; URINARY BLADDER NEOPLASMS;

EID: 84899833582     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5264     Document Type: Erratum

References (23)

1. Denzinger, S. et al. Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladdersparing approach? Eur. Urol. 53, 146-152 (2008).
2. Goebell, P. J. & Knowles, M. A. Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium. Urol. Oncol. 28, 409-428 (2010).
3. Gui, Y. et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat. Genet. 43, 875-878 (2011).
4. Balbas-Martinez, C. et al. Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy. Nat. Genet. 45, 1464-1469 (2013).
5. Guo, G. et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat. Genet. 45, 1459-1463 (2013).
6. Solomon, D. A. et al. Frequent truncating mutations of STAG2 in bladder cancer. Nat. Genet. 45, 1428-1430 (2013).
7. Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415-421 (2013).
8. Cappellen, D. et al. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat. Genet. 23, 18-20 (1999).
9. Sidransky, D., Boyle, J., Koch, W. & van der Riet, P. Oncogene mutations as intermediate markers. J. Cell. Biochem. Suppl. 17F, 184-187 (1993).
10. Gartel, A. L. & Radhakrishnan, S. K. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res. 65, 3980-3985 (2005).
11. Lianes, P. et al. Altered patterns of MDM2 and TP53 expression in human bladder cancer. J. Natl Cancer Inst. 86, 1325-1330 (1994).
12. Lacombe, L. et al. Analysis of p21WAF1/CIP1 in primary bladder tumors. Oncol. Res. 8, 409-414 (1996).
13. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315-322 (2014).
14. Abbas, T. & Dutta, A. p21 in cancer: intricate networks and multiple activities. Nat. Rev. Cancer 9, 400-414 (2009).
15. Liu, Y. & Bodmer, W. F. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. Proc. Natl Acad. Sci. USA 103, 976-981 (2006).
16. Lu, M. L. et al. Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods. Clin. Cancer Res. 8, 171-179 (2002).
17. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214-218 (2013).
18. Lunter, G. & Goodson, M. Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. Genome Res. 21, 936-939 (2011).
19. Lise, S. et al. Recessive mutations in SPTBN2 implicate β-III spectrin in both cognitive and motor development. PLoS Genet. 8, e1003074 (2012).
20. Cazier, J. B., Holmes, C. C. & Broxholme, J. GREVE: Genomic Recurrent Event ViEwer to assist the identification of patterns across individual cancer samples. Bioinformatics 28, 2981-2982 (2012).
21. Yau, C. et al. A statistical approach for detecting genomic aberrations in heterogeneous tumor samples from single nucleotide polymorphism genotyping data. Genome Biol. 11, R92 (2010).
22. Roth, A. et al. PyClone: statistical inference of clonal population structure in cancer. Nat. Methods 11, 396-398 (2014).
23. Gundem, G. et al. IntOGen: integration and data mining of multidimensional oncogenomic data. Nat. Methods 7, 92-93 (2010).